Balyasny Asset Management LLC View Ray, Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.66 - $3.97 $92,070 - $137,413	34,613 New	34,613 $126,000
Q2 2022 Aug 15, 2022	SELL	$2.42 - $4.05 $2.03 Million - $3.4 Million	-839,796 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.45 - $5.83 $563,650 - $952,487	-163,377 Reduced 16.29%	839,796 $3.29 Million
Q4 2021 Feb 14, 2022	BUY	$4.89 - $7.59 $4.91 Million - $7.61 Million	1,003,173 New	1,003,173 $5.53 Million
Q3 2021 Nov 15, 2021	SELL	$5.18 - $7.41 $3.86 Million - $5.52 Million	-745,411 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.94 - $6.75 $2.94 Million - $5.03 Million	745,411 New	745,411 $4.92 Million
Q1 2020 May 15, 2020	SELL	$1.35 - $4.05 $3.55 Million - $10.7 Million	-2,629,733 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.3 - $4.6 $5.23 Million - $10.5 Million	2,273,393 Added 637.98%	2,629,733 $11.1 Million
Q3 2019 Nov 14, 2019	BUY	$2.9 - $9.56 $1.03 Million - $3.41 Million	356,340 New	356,340 $1.03 Million
Q1 2019 May 15, 2019	SELL	$5.7 - $8.73 $552,392 - $846,033	-96,911 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.04 - $10.28 $189,005 - $385,510	37,501 Added 63.12%	96,911 $588,000
Q3 2018 Nov 14, 2018	BUY	$7.12 - $12.44 $422,999 - $739,060	59,410 New	59,410 $556,000
Q2 2018 Aug 14, 2018	SELL	$6.21 - $8.21 $2.03 Million - $2.69 Million	-327,500 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$6.26 - $10.12 $219,100 - $354,200	-35,000 Reduced 9.66%	327,500 $2.11 Million
Q4 2017 Feb 14, 2018	BUY	$5.6 - $9.9 $1.67 Million - $2.96 Million	299,018 Added 471.03%	362,500 $3.36 Million
Q3 2017 Nov 14, 2017	BUY	$4.73 - $6.16 $300,269 - $391,049	63,482	63,482 $366,000

Others Institutions Holding VRAY

# of Institutions

Shares Held

645K

Call Options Held

50K

Put Options Held

30K

View Full List

About ViewRay, Inc.

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

More about VRAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account